Empowering Drug Discovery with Human Genetics
Sequoia Genetics is a private limited company that works with pharma, biotech, investors, and academia by performing research that leverages genetic data to help inform drug discovery and development.
Our team is made up of biologists, clinicians, epidemiologists, statisticians, data scientists, bioinformaticians, and industry experts that have collectively published hundreds of research papers in the field and are vastly experienced in translating genetic insights to guide clinical development decisions.
Founded 2024
Incorporated in London, based at the Translation & Innovation Hub, White City — within the Imperial College London ecosystem.
World-Class Team
Biologists, clinicians, epidemiologists, statisticians, data scientists, bioinformaticians, and industry experts — all under one roof.
Research-Driven Insights
Hundreds of peer-reviewed publications. Proven expertise in translating genetic evidence into clinical development decisions.
Driving Innovation and Excellence in Human Genetics
Our Mission
Transform Drug Development
We are committed to transforming the drug development paradigm by optimising the translation of insights from genetic data.
Foster Transparency & Inclusivity
We aim to foster a culture of transparency, inclusivity, and continuous improvement – empowering our clients to achieve breakthroughs in science and healthcare.
Be a Catalyst for Change
Inspired by resilience, self-improvement, and social justice, we strive to be a catalyst for positive change in the drug development industry.
Our Vision
To become the go-to partner for genetic evidence generation in drug discovery and development — trusted by pharma, biotech, investors, and academia worldwide.
Pioneering Genetic Evidence
To set the standard for rigorous, reproducible, and translatable human genetic research — enabling decisions that reach patients with the right treatments.
A Globally Inclusive Science
To build and apply genetic insights across multi-ancestry cohorts, ensuring that the benefits of genomic medicine extend to diverse populations worldwide.
Performance Passion
Making it happen, doing it well, and owning the outcome. We hold ourselves to the highest standard of delivery in everything we produce.
Our Expertise and Our Values
At Sequoia Genetics, our expertise and our values are what differentiate us. These five principles define how we work every day.
Award-Winning Expertise
Recognized by industry leaders, our award-winning team has a proven record of delivering excellence across projects.
Unlocking Talent
We are all responsible for developing our people to be the best versions of themselves. Growth is not an afterthought — it is built into how we operate.
Open Engagement
We work together through open communication, recognising the value of everyone involved — whether that is a team member, a client, or a collaborator.
Uncompromised Integrity
Upholding the highest ethical standards in all our practices — ensuring that our advice and solutions are both scientifically sound and socially responsible. There are no shortcuts here.
R&D Excellence
Drive pioneering R&D initiatives to uncover novel insights and solutions — leveraging cutting-edge approaches to accelerate progress and improve outcomes across drug development.
Need to Know More?
A few things people often ask about Sequoia Genetics.
We perform research that leverages human genetic data to inform drug discovery and development. Our work helps pharma, biotech, investors, and academic partners decide which biological targets are most likely to succeed in clinical trials — based on genetic evidence rather than animal models alone.
Our team spans biologists, clinicians, epidemiologists, statisticians, data scientists, bioinformaticians, and industry experts. Collectively, the team has published hundreds of peer-reviewed research papers and brings deep experience in translating genetic insights into clinical development decisions.
Our core approach centres on Mendelian Randomisation (MR), pQTL analysis, GWAS, colocalization, and PheWAS. These methods use naturally occurring genetic variation as a tool to test causal relationships between biological targets and disease — providing evidence that is directly relevant to human clinical outcomes.
+ We work with pharmaceutical and biotechnology companies, investors, and academic institutions. Whether you need target validation, risk assessment for a drug programme, or genetic insights to support a publication or funding application, we can tailor our work to your needs.
Sequoia Genetics is headquartered in London, UK — currently at the Translation & Innovation Hub, 84 Wood Lane, White City, W12 0BZ, within the Imperial College London ecosystem. From June 2026, we will be operating from a new London office as part of our continued expansion, including our affiliate Wulfstan Analytics in Sri Lanka.
